NervGen Pharma Corp. (NGENF)
USD 2.02
(0.97%)
USD 2.02
(0.97%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -17.72 Million CAD | 21.96% |
| 2022 | -22.7 Million CAD | -77.08% |
| 2021 | -12.76 Million CAD | -15.04% |
| 2020 | -11.15 Million CAD | -13.44% |
| 2019 | -9.82 Million CAD | -634.0% |
| 2018 | -1.33 Million CAD | -11232.6% |
| 2017 | - CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -7.45 Million CAD | -1.97% |
| 2024 Q2 | -5.98 Million CAD | -21.37% |
| 2023 Q2 | -4.6 Million CAD | -1.42% |
| 2023 Q1 | -4.53 Million CAD | 31.89% |
| 2023 FY | - CAD | 22.36% |
| 2023 Q3 | -3.24 Million CAD | 29.54% |
| 2023 Q4 | -4.83 Million CAD | -49.14% |
| 2022 FY | - CAD | -77.08% |
| 2022 Q4 | -6.66 Million CAD | -38.11% |
| 2022 Q3 | -4.82 Million CAD | 22.68% |
| 2022 Q2 | -6.23 Million CAD | -24.49% |
| 2022 Q1 | -5.01 Million CAD | -21.59% |
| 2021 Q2 | -2.78 Million CAD | -26.73% |
| 2021 Q1 | -2.19 Million CAD | 48.16% |
| 2021 Q3 | -3.71 Million CAD | -33.43% |
| 2021 Q4 | -4.12 Million CAD | -10.89% |
| 2021 FY | - CAD | -15.04% |
| 2020 FY | - CAD | -13.44% |
| 2020 Q1 | -2.66 Million CAD | 7.87% |
| 2020 Q4 | -4.24 Million CAD | -116.91% |
| 2020 Q3 | -1.95 Million CAD | 14.35% |
| 2020 Q2 | -2.28 Million CAD | 14.46% |
| 2019 Q3 | -2.35 Million CAD | -51.03% |
| 2019 Q4 | -2.89 Million CAD | -22.94% |
| 2019 FY | - CAD | -634.0% |
| 2019 Q2 | -1.55 Million CAD | 42.13% |
| 2019 Q1 | -2.69 Million CAD | -255.4% |
| 2018 Q1 | -10.62 Thousand CAD | 0.0% |
| 2018 Q2 | -63.66 Thousand CAD | -499.28% |
| 2018 FY | - CAD | -11232.6% |
| 2018 Q3 | -506 Thousand CAD | -694.75% |
| 2018 Q4 | -758.42 Thousand CAD | -49.89% |
| 2017 FY | - CAD | 0.0% |
| 2017 Q3 | - CAD | 0.0% |
| 2017 Q4 | - CAD | 0.0% |
| 2017 Q2 | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Qrons Inc. | -40.08 Thousand USD | -44114.635% |
| Northwest Biotherapeutics, Inc. | -55.33 Million USD | 67.976% |
| Capstone Therapeutics Corp. | -1.74 Million USD | -912.667% |
| Adynxx, Inc. | - USD | Infinity% |
| Santhera Pharmaceuticals Holding AG | 94.03 Million USD | 118.845% |
| ProtoKinetix, Incorporated | -367.22 Thousand USD | -4725.886% |
| BioStem Technologies, Inc. | -7.55 Million USD | -134.611% |
| Evofem Biosciences, Inc. | -17.37 Million USD | -2.025% |
| Skye Bioscience, Inc. | -13.54 Million USD | -30.811% |
| Rebus Holdings, Inc. | -951 Thousand USD | -1763.477% |
| Arch Therapeutics, Inc. | -3.88 Million USD | -356.236% |
| Burzynski Research Institute, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | -2702.261% |
| Nascent Biotech, Inc. | 527.43 Thousand USD | 3459.985% |
| Acro Biomedical Co., Ltd. | -15.86 Million USD | -11.67% |
| Eiger BioPharmaceuticals, Inc. | -71.03 Million USD | 75.053% |
| Nanobac Pharmaceuticals, Incorporated | -5.92 Million USD | -198.903% |
| Institute of Biomedical Research Corp. | -239.15 Thousand USD | -7310.273% |
| SQZ Biotechnologies Company | -64.14 Million USD | 72.371% |
| Intellipharmaceutics International Inc. | -2.64 Million USD | -570.146% |
| Propanc Biopharma, Inc. | -1.53 Million USD | -1053.718% |
| Mesoblast Limited | -62.38 Million USD | 71.595% |
| Marizyme, Inc. | -34.28 Million USD | 48.305% |
| Genus plc | 73.7 Million USD | 124.046% |
| VioQuest Pharmaceuticals, Inc. | -6.61 Million USD | -168.042% |
| Pharming Group N.V. | 9.87 Million USD | 279.424% |
| Therapeutic Solutions International, Inc. | -1.48 Million USD | -1091.443% |
| CNBX Pharmaceuticals Inc. | -3.54 Million USD | -399.624% |
| Nymox Pharmaceutical Corporation | -8.77 Million USD | -102.025% |
| ContraFect Corporation | -64.99 Million USD | 72.735% |
| PsyBio Therapeutics Corp. | -4.52 Million USD | -291.536% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.4 Million USD | -1164.201% |
| IMV Inc. | -35.52 Million USD | 50.113% |
| AXIM Biotechnologies, Inc. | -2.32 Million USD | -662.609% |
| MultiCell Technologies, Inc. | -518.04 Thousand USD | -3320.868% |
| ONE Bio Corp. | 13.61 Million USD | 230.182% |
| Accustem Sciences Inc. | -3.74 Million USD | -373.03% |
| RVL Pharmaceuticals plc | -48.22 Million USD | 63.254% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | -1298.565% |
| Q BioMed Inc. | -617.62 Thousand USD | -2769.311% |
| Emmaus Life Sciences, Inc. | 3.57 Million USD | 596.127% |
| Mosaic ImmunoEngineering Inc. | -2.28 Million USD | -675.739% |
| Biomind Labs Inc. | -1.03 Million USD | -1612.985% |
| American Oriental Bioengineering, Inc. | -39.63 Million USD | 55.29% |
| Provectus Biopharmaceuticals, Inc. | -2.89 Million USD | -512.713% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.16 Million USD | -147.465% |
| GlobeStar Therapeutics Corporation | 6724.00 USD | 263658.418% |
| THC Farmaceuticals, Inc. | -25 Thousand USD | -70786.672% |
| Curative Biotechnology, Inc. | -2.5 Million USD | -608.311% |
| GB Sciences, Inc. | -1.41 Million USD | -1148.106% |
| Alpha Cognition Inc. | -9.7 Million USD | -82.592% |
| HST Global, Inc. | -5303.00 USD | -334081.935% |
| CSL Limited | 4.78 Billion USD | 100.37% |
| Wesana Health Holdings Inc. | -2.05 Million USD | -761.53% |
| Halberd Corporation | -74.27 Thousand USD | -23758.248% |
| Enzolytics Inc. | -2.12 Million USD | -735.128% |
| Agentix Corp. | -1.37 Million USD | -1191.897% |
| Resverlogix Corp. | -11.74 Million USD | -50.925% |
| Nuo Therapeutics, Inc. | -3.06 Million USD | -478.569% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -216.02 Million USD | 91.796% |
| Enzon Pharmaceuticals, Inc. | 1.21 Million USD | 1556.176% |
| Endonovo Therapeutics, Inc. | 8.85 Million USD | 300.159% |
| RespireRx Pharmaceuticals Inc. | -1.49 Million USD | -1082.307% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | 378.84 Thousand USD | 4777.827% |
| AVAX Technologies, Inc. | -6.11 Million USD | -189.918% |
| Zenith Capital Corp. | -8.6 Million USD | -105.922% |
| Genscript Biotech Corporation | -248.71 Million USD | 92.875% |
| Ember Therapeutics, Inc. | -17.42 Thousand USD | -101625.894% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -2.44 Million USD | -624.38% |
| WPD Pharmaceuticals Inc. | -176.02 Thousand USD | -9967.736% |
| Cotinga Pharmaceuticals Inc. | -1.92 Million USD | -822.566% |
| Kadimastem Ltd | -2.62 Million USD | -575.27% |
| Helix BioMedix, Inc. | -1.04 Million USD | -1593.727% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -181.08 Thousand USD | -9686.219% |
| LadRx Corporation | 412.28 Thousand USD | 4398.423% |
| Cell Source, Inc. | -4.27 Million USD | -314.782% |
| Regen BioPharma, Inc. | 1.46 Million USD | 1308.881% |
| Regen BioPharma, Inc. | -936.94 Thousand USD | -1791.423% |
| NovAccess Global Inc. | -1.03 Million USD | -1612.574% |
| Affymax, Inc. | -14.29 Million USD | -23.971% |
| Itoco Inc. | -1.86 Million USD | -848.192% |
| Rasna Therapeutics, Inc. | -379.62 Thousand USD | -4568.265% |
| Pathfinder Cell Therapy, Inc. | -1.11 Million USD | -1487.963% |
| Mobile Lads Corp. | -2.24 Million USD | -690.737% |
| CytoDyn Inc. | -18.02 Million USD | 1.705% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.02 Thousand USD | -22324.259% |
| NanoSphere Health Sciences Inc. | -12.22 Thousand USD | -144815.103% |
| Alseres Pharmaceuticals, Inc. | -485.67 Thousand USD | -3548.851% |
| SYBLEU INC | -141.57 Thousand USD | -12417.866% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.06 Million USD | -1568.691% |
| International Stem Cell Corporation | 202 Thousand USD | 8873.103% |
| Bioxytran, Inc. | -3.82 Million USD | -363.9% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -52.64 Thousand USD | -33565.783% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.46 Million USD | -619.828% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -35.86 Million USD | 50.593% |
| Adhera Therapeutics, Inc. | - USD | Infinity% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -45 Thousand USD | -39281.484% |
| Innovation Pharmaceuticals Inc. | -2.73 Million USD | -547.249% |
| Neutra Corp. | -181.24 Thousand USD | -9677.634% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | 12.091% |
| PureTech Health plc | -11.62 Million USD | -52.418% |
| Coeptis Therapeutics, Inc. | -20.15 Million USD | 12.085% |
| IXICO plc | -707 Thousand USD | -2406.601% |
| IntelGenx Technologies Corp. | -7.68 Million USD | -130.601% |
| Gelesis Holdings, Inc. | -48.34 Million USD | 63.344% |
| CSL Limited | 4.73 Billion USD | 100.374% |
| Cellectis S.A. | -92.63 Million USD | 80.87% |